SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is drawing attention amid a cybersecurity-sector selloff, with traders linking the pressure largely to Fortinets earnings reaction and broader weakness in software stocks. Some see the drop as sympathy selling and a buying opportunity, while others argue CRWDs rich valuation leaves it vulnerable to further declines.

Tidal Trust II - YieldMax Semiconductor Portfolio Option Income ETF

YieldMax Semiconductor Portfolio Option Income ETF

CHPY is drawing attention amid a sharp pullback across semiconductor and AI-related stocks, which traders attribute to de-risking and concerns about AI valuations and spending. Some holders are buying the dip and focusing on long-term chip demand and weekly income, while skeptics worry about further losses, declining distributions, and NAV erosion.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgans quarterly results missed expectations, with weaker fixed-income trading and securities losses weighing on the report; stronger net interest income and lending provided an offset. Traders are debating the stocks resilient, volatile reaction despite the earnings miss.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios post-earnings selloff is centered on a softer fourth-quarter organic-growth outlook, which traders see as a deceleration despite the quarterly beat and raised full-year guidance. The community is divided between waiting for support after the sharp drop and viewing the weaker outlook and slowing messaging growth as reasons to stay cautious.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is drawing attention amid a prolonged selloff and fresh lows, with traders citing Chinese EV weakness, analyst downgrades, and concerns about demand, profitability, and upcoming delivery guidance. Bulls point to rising deliveries, exports, and technology initiatives, but debate why those developments have not supported the share price.

Palo Alto Networks, is a cybersecurity company that provides cybersecurity platforms and services to enterprises, organizations, service providers, and government entities. Its offerings include network and AI security, cloud security, security operations, and identity security solutions. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto is under pressure alongside other cybersecurity stocks after Fortinets weaker service-revenue outlook sparked sector-wide sympathy selling, despite its stronger results elsewhere. Traders debate whether the pullback is overdone given PANWs recurring-security business, while others point to elevated valuations and growth concerns.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Brazilian approval of Transoceans Valaris merger has traders focused on the deals expected scale and synergies, while elevated short interest is fueling squeeze speculation. Recent offshore contract wins and higher day rates bolster the bullish case, but some traders remain concerned about share dilution, debt and the stocks muted response to positive developments.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is drawing attention amid sharp crude-oil swings tied to U.S.-Iran tensions, Strait of Hormuz supply concerns, and shifting reports about a possible deal. Traders are divided between bullish bets on continued disruption and expectations of an oil pullback if tensions ease, with some also flagging the risks of trading a leveraged fund in volatile markets.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

Discussion centers on volatile broad-market moves and the Dows relative strength versus tech-heavy indexes, with traders debating whether the rotation into blue chips can persist or signals wider weakness. Rising Treasury yields, Fed policy uncertainty, and Iran-related oil concerns are recurring macro risks, while bullish and crash-focused views remain sharply divided.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novos upcoming Q3 report is the main focus, with traders watching whether oral Wegovy demand and guidance can support a recovery amid competition from Eli Lilly. Bulls anticipate stronger results and see the pills prescription momentum as a positive, while skeptics point to market-share pressure, management concerns, and the stocks prolonged weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate

Enveric Biosciences posts positive preclinical data for EB-003, showing favorable absorption and safety for psychiatric therapies.read more...

Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced positive results from recently completed IND-enabling in vitro Absorption...

Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that it has received a Notice of Allowance from the United States Patent and Trademark...

Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that Joseph Tucker, Ph.D., CEO of Enveric will deliver a virtual presentation at the...

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today reported financial results for the second quarter ended June 30, 2026, and provided a...

Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Candidate

Enveric Biosciences reports new preclinical data supporting the non-hallucinogenic profile of its lead psychiatric drug candidate, EB-003.read more...

Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced new preclinical data that further supports the growing body of evidence reinforcing...

Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today welcomed the U.S. Food and Drug Administration's (FDA) recent release of finalized guidance for...

Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced its participation in the B. Riley Securities Mind, Muscle & Vision Summit, being held...

Enveric Biosciences Announces Participation in 2026 BIO International Convention

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that the company is participating in the BIO International Convention being held June...

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

Cannabis, Psychedelics, And AI Stocks Are Wall Street’s Biggest Winners This Week

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>While the S&amp;P 500 closed up about 0.8% on Friday, the Nasdaq Composite rose 1.63%.&nbsp;</li><li>Trump announcements and solid corporate earnings drove significant rallies this week.</li></ul>U.S. equities closed out a highly active week on Friday, with the S&amp;P 500 and Nasdaq Composite ending the week near all-time highs, supported by strong earnings in the chipmaking and AI space, while policy support for cannabis and psychedelic research drove a few mid and small-cap pharma stocks higher.While the S&amp;P 500 closed up about 0.8% on Friday, marking its fourth consecutive week of gains, the Nasdaq Composite rose 1.63%. &nbsp;The following stocks clocked the highest gains this week:Akanda Corp. (<a href="https://stocktwits.com/symbol/AKAN">AKAN</a>): Shares of Akanda exploded this week, surging more than 300% after the Trump administration advanced plans to reclassify marijuana as a Schedule III drug. The broader cannabis sector ignited on the policy shift, and AKAN recorded single-day gains as high as 214%.Enveric Biosciences (<a href="https://stocktwits.com/symbol/ENVB">ENVB</a>): ENVB shares rocketed higher early in the week after President Trump’s executive order directing federal agencies to accelerate research and approval pathways for psychedelic therapies. The small-cap developer of psychedelic medicines for mental health surged more than 100% in a single session as investors bet on faster regulatory tailwinds in the sector. The company clocked its best week ever.MaxLinear (<a href="https://stocktwits.com/symbol/MXL">MXL</a>): MXL climbed sharply after the semiconductor company delivered a strong first-quarter earnings beat on Thursday and issued upbeat guidance that highlighted robust demand for its optical and connectivity chips in AI data centers. Revenue rose 43% year-over-year, beating estimates, and the raised outlook for the current quarter sent shares surging more than 75% in Friday’s session. The stock closed 130% higher this week, marking its best week to date.Trio-Tech International (<a href="https://stocktwits.com/symbol/TRT">TRT</a>): TRT stock soared as much as 67% on Thursday to a new all-time high as momentum traders piled into the stock. The company provides reliability testing services and specialized equipment that help chipmakers validate and stress-test products before they reach customers amid an overall increase in chip demand driven by AI infrastructure and data centers. The stock closed at $16.52 on Friday, after opening at just $7.05 at the week’s onset.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/arwr-rallies-this-week-as-europe-edges-closer-to-redemplo-approval-amid-analyst-optimism/cZBhLOHRecF">ARWR Rallies 7% This Week As Europe Edges Closer To Redemplo Approval Amid Analyst Optimism</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of GNTX rise on Friday (Representative image: Getty Images)

AKAN, ENVB, MXL, and TRT were the biggest gainers in the week ended April 24. 

Akanda Corp

MaxLinear Inc

Trio-Tech International

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$ENVB what a pathetic ass stock, company and ceo. This shit was suppose to go to 100$ so everyone on here was saying back in 2020-2023 and it’s even worse off with shareholder dilution. Black hole scam

Your Wifes Boyfriend

$ENVB dumbass shareholders pay the salary of these con artist at this nom profitable company

$ENVB Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate

by Vandana Singh Benzinga Staff Writer

Feed

News

Sentiment

Fundamentals

Info

ENVB Enveric Biosciences Inc

Fundamentals

Latest ENVB News